Treatment for Patients with Acute Ischemic Stroke Presenting beyond Six Hours of Ischemic Symptom Onset : Effectiveness of Intravenous Direct Thrombin Inhibitor, Argatroban.
Jung Soo Park, Seung Soo Park, Eun Jeong Koh, Jong Pil Eun, Ha Young Choi
J Korean Neurosurg Soc. 2010;47(4):258-264. DOI: https://doi.org/10.3340/jkns.2010.47.4.258
Citations to this article as recorded by 
Efficacy and safety of argatroban in treatment of acute ischemic stroke: A meta-analysis
Bin Lv, Fang-Fang Guo, Jia-Cai Lin, Feng Jing
World Journal of Clinical Cases.2022; 10(2): 585. CrossRef
Therapeutic Effect and Safety of Argatroban in Cerebral Territory Infarction
Yang-Hyun Lee, In-Uk Song, Tae-Won Kim, Hyun-Ji Cho, Jeong-Wook Park, Kwang-Soo Lee
Journal of Neurocritical Care.2016; 9(2): 132. CrossRef
Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapy
Monika Killer, Eugen Trinka, Jörg Kraus, Erasmia Broussalis
Expert Opinion on Drug Discovery.2011; 6(4): 353. CrossRef
Differences in fibrin fiber diameters in healthy individuals and thromboembolic ischemic stroke patients
Etheresia Pretorius, Helena Steyn, Mia Engelbrecht, Albe C. Swanepoel, Hester M. Oberholzer
Blood Coagulation & Fibrinolysis.2011; 22(8): 696. CrossRef